✦ LIBER ✦

Structure–activity relationships of methyl-lysine reader antagonists

✍ Scribed by Herold, J. Martin ;James, Lindsey Ingerman ;Korboukh, Victoria K. ;Gao, Cen ;Coil, Kaitlyn E. ;Bua, Dennis J. ;Norris, Jacqueline L. ;Kireev, Dmitri B. ;Brown, Peter J. ;Jin, Jian ;Janzen, William P. ;Gozani, Or ;Frye, Stephen V.

Book ID: 118140192
Publisher: The Royal Society of Chemistry
Year: 2012
Tongue: English
Weight: 414 KB
Volume: 3
Category: Article
ISSN: 2040-2503
DOI: 10.1039/c1md00195g

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Structure - activity relationships in ne

Structure - activity relationships in neurokinin a antagonists

✍ S. Lovas; J. Allen; M. Murnin; D.H. Guthrie; G.B. Irvine; D. Smith; R.F. Murphy 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Structure-activity relationships for his

Structure-activity relationships for histamine H2-antagonists

✍ Fulvia M.L.G. Stamato; Marco A. Perez; Elson Longo 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 351 KB

Structure-activity relationships of comp

Structure-activity relationships of competitive NMDA receptor antagonists

✍ Nam S. Cheung; Daniel O'Callaghan; Mary C. Ryan; Renée Dutton; Margaret G. Wong; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 528 KB

Quantitative structure–activity relation

Quantitative structure–activity relationships of α1adrenergic antagonists

✍ Slavica Eric; Tomaz Solmajer; Jure Zupan; Marjana Novic; Marko Oblak; Danica Agb 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 433 KB

Structure–activity relationships of aryl

Structure–activity relationships of arylbenzofuran H3 receptor antagonists

✍ Gregory A. Gfesser; Ramin Faghih; Youssef L. Bennani; Michael P. Curtis; Timothy 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Synthesis and structure—activity relatio

Synthesis and structure—activity relationships of new muscarinic antagonists

✍ Victor I. Cohen; Raymond E. Gibson; Richard C. Reba 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB

In an attempt to develop more selective muscarinic acetylcholine receptor (m-AcChR) antagonists, (R)-1-azabicyclo[2.2.2]oct-3-yl-thioxanthene-9-carboxylate, (R,S)-thiochromane-4-carboxylate, and (R,S)-chromane-4-carboxylate were synthesized. Evaluation of the binding affinities of these compounds to